Brief: Extrawell Pharmaceutical Sees Increase In FY Profit Of About HK$260 Mln
17/06/2022 14:36
June 17 (Reuters) - Extrawell Pharmaceutical Holdings Ltd
0858.HK :
* SEES INCREASE IN PROFIT OF ABOUT HK$260 MILLION FOR YEAR
* EXPECTED RESULT DUE TO A NON-CASH ITEM FROM FAIR VALUE
CHANGE OF
GROUP'S INVESTMENTS IN CONVERTIBLE BONDS
Further company coverage: 0858.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Extrawell Pharmaceutical Holdings
See all newsBrief: Extrawell Pharmaceutical Abandons Negotiations For Possible Sale Of Convertible Bonds
Brief: Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Brief: Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
Brief: Extrawell Pharmaceutical's Unit To Buy Back 10.06% Of Its Stake For RMB4.4 Million